8-K current report · filed Jun 17, 2026

Clorox (CLX) 8-K Current Report: June 17, 2026

Item 5.02Item 7.01Item EX-99.1CLX overview

Short answer

Clorox (CLX) filed an 8-K current report with the SEC on June 17, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Officer or director appointment referenced, but the provided excerpt does not identify the appointee or role.

Clorox 8-K event analysis

AI summary of each reported item and its exhibits

Item 5.02 · Departure/Election of Directors or Officers

  • Officer or director appointment referenced, but the provided excerpt does not identify the appointee or role
  • No reportable related-party transactions under Regulation S-K Items 401(d) or 404(a)‑

Item 7.01 · Regulation FD Disclosure

  • Regulation FD filing furnishes a press release as Exhibit 99.1
  • Exhibit 99.1 contains the substantive developments relevant to investors

Item EX-99.1 · Exhibit EX-99.1

  • Simplified structure consolidates business-unit leadership under Chris Hyder as COO, targeting faster execution and stronger operational accountability
  • Nina Barton becomes chief growth and strategy officer, overseeing innovation, commercial functions, and portfolio shaping
  • Resource priorities remain focused on faster-growing health and hygiene categories under the IGNITE strategy
  • Leadership changes occur amid the Board’s comprehensive search for a new CEO, announced May 28
  • Potential investor impact: execution improvement and portfolio optimization could support profitable growth, but CEO succession remains an unresolved catalyst

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Clorox 8-K filings

Get the next CLX 8-K as it lands

Follow CLX for push alerts, or ask the research agent what this filing means.